PPD PPD (Pharmaceutical Product Development) is a company that provides drug development and laboratory solutions. | ![]() PRA Health Sciences PRA Health Sciences is a contract research organization that provides outsourced clinical development services to the biotechnology and pharmaceutical industries. | ![]() IQVIA IQVIA Holdings (formerly known as QuintilesIMS) is a company that offers clinical research services, data analysis, and information solutions for the life sciences and healthcare industries. | ![]() Fortrea US Fortrea US (formerly known as Labcorp Drug Development) is a company that specializes in clinical development and patient access solutions. | ||
Founding Date | Founding Date 1985 | Founding Date 1987 | Founding Date 1976 | Founding Date 2016 | Founding Date 1993 |
Type | Type Subsidiary | Type Public | Type Subsidiary | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Wilmington, US HQ Buenos Aires, AR Melbourne, AU Brussels, BE Zaventem, BE São Paulo, BR São Paulo, BR see more | Locations Raleigh, US HQ Buenos Aires, AR Haymarket, AU South Yarra, AU Minsk, BY Mechelen, BE São Paulo, BR see more | Locations Durham, US HQ Buenos Aires, AR Melbourne, AU North Sydney, AU Wien, AT Antwerpen, BE Wijnegem, BE see more | Locations Durham, US HQ | |
Employees | Employees 24,5842% decrease | Employees 65,694 | Employees 18,1003% increase | Employees 93,000 | Employees 15,099 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 9.5 b | Valuation ($) N/A | Valuation ($) 39.4 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $4.7b (FY, 2020) | Revenue (est.) €7.3b (FY, 2025) | Revenue (est.) $3.2b (FY, 2020) | Revenue (est.) $16.3b (FY, 2025) | Revenue (est.) $5.7b (FY, 2022) |
Cost of goods | Cost of goods $1.7b (FY, 2020) | Cost of goods €2.3b (FY, 2025) | Cost of goods $2.3b (FY, 2020) | Cost of goods $10.9b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $3b (FY, 2020) | Gross profit €5b (FY, 2025) | Gross profit $868.6m (FY, 2020) | Gross profit $5.4b (FY, 2025) | Gross profit N/A |
Net income | Net income $160.6m (FY, 2020) | Net income €473m (FY, 2025) | Net income $197m (FY, 2020) | Net income $1.4b (FY, 2025) | Net income N/A |
Operating ⚠ | |||||
Backlog | Backlog $9.5b (Q3, 2021) | Backlog N/A | Backlog N/A | Backlog $27.2b (FY, 2022) | Backlog N/A |
Countries | Countries 46 (FY, 2020) | Countries 62 (FY, 2023) | Countries N/A | Countries 100 (FY, 2022) | Countries N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 30m | Total funding raised N/A | Total funding raised $ 3.2b | Total funding raised $ 1.3m |

Eurofins Scientific is a life sciences company providing laboratory services.
View company
PRA Health Sciences is a contract research organization that provides outsourced clinical development services to the biotechnology and pharmaceutical industries.
View company
IQVIA Holdings (formerly known as QuintilesIMS) is a company that offers clinical research services, data analysis, and information solutions for the life sciences and healthcare industries.
View company
Fortrea US (formerly known as Labcorp Drug Development) is a company that specializes in clinical development and patient access solutions.
View company